Glaxo's Tykerb reduces breast cancer stem cells - Reuters

The Money Times Glaxo's Tykerb reduces breast cancer stem cells Reuters - 1 hour ago LONDON, April 17 (Reuters) - GlaxoSmithKline Plc's (GSK.L: Quote, Profile, Research) new cancer drug Tykerb can decrease tumour-causing breast cancer stem cells, offering the hope it may help stop disease from recurring, scientists said on Thursday. ...

Write comment to this article:

Subject:

Name:

email or site:

Code: